Patterns and risk factors of recurrence in low-risk early-stage cervical adenocarcinoma treated with surgery alone: implications on risk group stratification

被引:1
|
作者
Bae, Bong Kyung [1 ]
Cho, Won Kyung [1 ]
Kim, Byoung-Gie [2 ]
Choi, Chel Hun [2 ]
Kim, Tae-Joong [2 ]
Lee, Yoo-Young [2 ]
Lee, Jeong-Won [2 ]
Park, Won [1 ]
机构
[1] Samsung Med Ctr, Dept Radiat Oncol, Seoul, South Korea
[2] Samsung Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea
关键词
Adenocarcinoma; Pathology; PELVIC RADIATION-THERAPY; RADICAL HYSTERECTOMY; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; ADJUVANT THERAPY; UTERINE CERVIX; CARCINOMA; CANCER; CLASSIFICATION; INVASION;
D O I
10.1136/ijgc-2022-003971
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveCervical adenocarcinoma has poorer outcomes compared with squamous cell carcinoma; however, treatment is identical irrespective of histologic sub-types. This study aimed to investigate the patterns and risk factors of recurrence following surgery alone for low-risk early-stage cervical adenocarcinoma. MethodsWe retrospectively reviewed patients who underwent surgery alone for low-risk early-stage cervical adenocarcinoma between January 2001 and December 2018 in a single institution. Baseline clinicopathological characteristics were collected to identify the factors associated with recurrence-free survival. ResultsA total of 252 patients met the inclusion criteria. Most patients underwent radical hysterectomy (218 patients, 86.5%) and had usual type endocervical adenocarcinoma (190 patients, 75.4%). The International Federation of Gynecology and Obstetrics 2018 stage was IA1 in 72 patients (27.4%), IA2 in 58 (22.1%), IB1 in 51 (19.4%), and IB2 in 71 patients (27.0%). With a median follow-up of 70.4 months (range 6.2-252.5 months), 5-year survival rates were as follows: locoregional recurrence-free survival, 93.0%; recurrence-free survival, 89.6%; overall survival, 94.7%. The recurrence patterns were local in nine patients (32.1%), regional in five patients (17.8%), distant in 10 patients (35.7%), local and distant in one patient (3.6%), regional and distant in two patients (7.2%), and locoregional and distant in one patient (3.6%). In multivariable analysis, negative human papillomavirus (HPV) status (HR 7.314; p<0.001) and deep cervical stromal invasion (HR 5.110; p=0.003) were associated with poor locoregional recurrence-free survival. Patients were stratified based on the number of risk factors and a statistically significant difference in locoregional recurrence-free survival was observed: 5-year survival rates of 99.0%, 84.2%, and 50.0% for patients with 0, 1, and 2 risk factors (0 vs 1, p=0.001; 1 vs 2, p=0.011). ConclusionSurgery alone for low-risk early-stage cervical adenocarcinoma was associated with favorable outcomes over a long follow-up period. Patients with the highest risk of recurrence were those with a negative HPV status and deep cervical stromal invasion. Additional management following surgery may be considered in patients with these risk factors.
引用
收藏
页码:1524 / 1530
页数:7
相关论文
共 50 条
  • [31] Commentary: All that glitters isn't gold: Defining low-risk lesions in early-stage esophageal adenocarcinoma
    Sesti, Joanna
    Paul, Subroto
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 162 (04): : 1280 - 1281
  • [32] Is there an adequate risk stratification? Are low-risk patients treated better than high-risk patients?
    Hamm, Christian
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2006, 131 (47) : S203 - S203
  • [33] Can Low-Risk, Early-Stage Patients with Hodgkin Lymphoma Be Spared Radiotherapy?
    Gregory M. Cote
    George P. Canellos
    Current Hematologic Malignancy Reports, 2011, 6
  • [34] Clinical implication of surgically treated early-stage cervical cancer with multiple high-risk factors
    Matsuo, Koji
    Mabuchi, Seiji
    Okazawa, Mika
    Kawano, Mahiru
    Kuroda, Hiromasa
    Kamiura, Shoji
    Kimura, Tadashi
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2015, 26 (01) : 3 - 11
  • [35] Can Low-Risk, Early-Stage Patients with Hodgkin Lymphoma Be Spared Radiotherapy?
    Cote, Gregory M.
    Canellos, George P.
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2011, 6 (03) : 180 - 186
  • [36] Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma
    Kinugasa, Hideaki
    Nouso, Kazuhiro
    Takeuchi, Yasuto
    Yasunaka, Tetsuya
    Onishi, Hideki
    Nakamura, Shin-ichiro
    Shiraha, Hidenori
    Kuwaki, Kenji
    Hagihara, Hiroaki
    Ikeda, Fusao
    Miyake, Yasuhiro
    Takaki, Akinobu
    Yamamoto, Kazuhide
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (04) : 421 - 426
  • [37] Risk factors for recurrence after transarterial chemoembolization for early-stage hepatocellular carcinoma
    Hideaki Kinugasa
    Kazuhiro Nouso
    Yasuto Takeuchi
    Tetsuya Yasunaka
    Hideki Onishi
    Shin-ichiro Nakamura
    Hidenori Shiraha
    Kenji Kuwaki
    Hiroaki Hagihara
    Fusao Ikeda
    Yasuhiro Miyake
    Akinobu Takaki
    Kazuhide Yamamoto
    Journal of Gastroenterology, 2012, 47 : 421 - 426
  • [38] SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer
    Manzour, Nabil
    Chiva, Luis
    Chacon, Enrique
    Martin-Calvo, Nerea
    Boria, Felix
    Minguez, Jose A.
    Alcazar, Juan L.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (08) : 4819 - 4829
  • [39] SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer
    Nabil Manzour
    Luis Chiva
    Enrique Chacón
    Nerea Martin-Calvo
    Felix Boria
    José A. Minguez
    Juan L. Alcazar
    Annals of Surgical Oncology, 2022, 29 : 4819 - 4829
  • [40] Survival outcomes of minimally invasive versus open radical hysterectomy for low-risk, early-stage cervical cancer
    Summers, Garth
    Tierney, Brent
    Crotzer, David
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2020, 149 (03) : 380 - 381